Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Xoma reported $-10170000 in EBIT for its fiscal quarter ending in March of 2023.

Ebit Change
Agios Pharmaceuticals AGIO:US USD -90613000 8.56M
Ardelyx ARDX:US USD -25664000 37.81M
BioMarin Pharmaceutical BMRN:US USD 61.45M 85.95M
Bluebird Bio BLUE:US USD -84493000 7.93M
Celldex Therapeutics CLDX:US USD -32471000 4.59M
Chimerix CMRX:US USD -24218000 404K
Curis CRIS:US USD -11627000 1.41M
Eli Lilly LLY:US USD 1.6B 515.6M
Incyte Corp INCY:US USD 29.6M 63.75M
Intercept Pharmaceuticals ICPT:US USD -31632000 13.65M
Life Technologies LIFE:US USD -12787000 4.84M
MacroGenics MGNX:US USD -38426000 50.41M
Novartis NOVN:VX USD 3.23B 123M
Novartis NVS:US USD 3.23B 123M
Pfizer PFE:US USD 6.91B 1.1B
Regeneron Pharmaceuticals REGN:US USD 1B 174M
Xoma XOMA:US USD -10170000 3.96M